Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34pos Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction
Mesenchymal stem/stromal cells (MSCs) represent a promising cell source for research and therapeutic applications, but their restricted ex vivo propagation capabilities limit putative applications. Substantial self-renewing of stem cells can be achieved by reprogramming cells into induced pluripoten...
Saved in:
Main Authors: | Mohsen Moslem, Irina Eberle, Iuliia Weber, Reinhard Henschler, Tobias Cantz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2015/843058 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protocol for the generation of HLF+ HOXA+ human hematopoietic progenitor cells from pluripotent stem cells
by: Sherry Li Zheng, et al.
Published: (2025-03-01) -
Hepatic Differentiation of Murine Disease-Specific Induced Pluripotent Stem Cells Allows Disease Modelling In Vitro
by: Reto Eggenschwiler, et al.
Published: (2011-01-01) -
Stem Cell Therapy for the Treatment of Amyotrophic Lateral Sclerosis: Comparison of the Efficacy of Mesenchymal Stem Cells, Neural Stem Cells, and Induced Pluripotent Stem Cells
by: Lauren Frawley, et al.
Published: (2024-12-01) -
Advances in Induced Pluripotent Stem Cell Technologies
by: Rajarshi Pal, et al.
Published: (2012-01-01) -
Induced Pluripotent Stem Cells in Cardiovascular Medicine
by: Toru Egashira, et al.
Published: (2011-01-01)